Last reviewed · How we verify

NCT06360536: OVERCOME-IT

Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women

Recruiting now NA Last updated 2 February 2026
What this trial tests

NA trial testing Resistance Training in Overweight or Obesity in 36 participants. Currently enrolling.

Timeline
4 June 2025
Primary endpoint
1 June 2026
30 June 2026

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment36
Start date4 June 2025
Primary completion1 June 2026
Estimated completion30 June 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

Adults 30 to 64, female only, with Overweight or Obesity or Prediabetes or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to collect preliminary data on the feasibility, acceptability, and potential effects of a novel, remotely delivered resistance training program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Resistance Training

Trials testing the same drug.

Other recruiting trials for Overweight or Obesity

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06360536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing